Topical antimicrobial pharmaceutical compositions and methods
First Claim
1. A topical antimicrobial or antiparasitic pharmaceutical composition comprising a safe and effective amount of a mixture comprising:
- (a) a glycerol monoester of lauric acid present in an amount of about 0.05 to about 2.0 percent by weight of the composition;
(b) a binary mixture of fatty acids comprising;
(i) a first fatty acid comprising capric acid, and(ii) a second fatty acid comprising caprylic acid;
wherein (a) and (b) are present at a level such that the weight;
weight ratio of (a);
(b) is about 10;
1 to 1;
10, and wherein (i) and (ii) are present in a weight;
weight ratio of about 1;
10 to about 10;
1 and said binary mixture is present in an amount of about 0.5 to about 8.0 percent by weight of the composition;
(c) a pharmaceutically-acceptable carrier which includes lactic acid; and
(d) a surfactant which comprises a block copolymer of propylene oxide and ethylene oxide.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention discloses a topical antimicrobial and anti-parasite pharmaceutical composition and methods of using the same. The topical antimicrobial pharmaceutical composition includes a safe and effective amount of an ethoxylated or propoxylated glycerol fatty acid ester and a pharmaceutically acceptable carrier. Also disclosed is a topical antimicrobial pharmaceutical composition including a safe and effective amount of a tertiary mixture including, a glycerol fatty acid ester, a binary mixture of fatty acids including a first fatty acid antimicrobial agent selected from C6 to C18 fatty acids, and a second fatty acid antimicrobial agent selected from C6 to C18 fatty acids, and a pharmaceutically acceptable carrier. Further disclosed is a topical antimicrobial pharmaceutical composition including a safe and effective amount of an ethoxylated or propoxylated glycerol fatty acid ester, a binary fatty acid mixture including, a first fatty acid antimicrobial agent selected from C6 to C18 fatty acid and the second fatty acid antimicrobial agent selected from C6 to C18 fatty acids, where the second fatty acid is not the same as the first fatty acid, and a pharmaceutically acceptable carrier. Further disclosed is a method of treating and preventing microbial related skin conditions in humans or lower animals comprising topically applying, to the afflicted situs of a human of lower animal in need of such treatment, a safe and effective amount of the above composition.
213 Citations
18 Claims
-
1. A topical antimicrobial or antiparasitic pharmaceutical composition comprising a safe and effective amount of a mixture comprising:
-
(a) a glycerol monoester of lauric acid present in an amount of about 0.05 to about 2.0 percent by weight of the composition; (b) a binary mixture of fatty acids comprising; (i) a first fatty acid comprising capric acid, and (ii) a second fatty acid comprising caprylic acid; wherein (a) and (b) are present at a level such that the weight;
weight ratio of (a);
(b) is about 10;
1 to 1;
10, and wherein (i) and (ii) are present in a weight;
weight ratio of about 1;
10 to about 10;
1 and said binary mixture is present in an amount of about 0.5 to about 8.0 percent by weight of the composition;(c) a pharmaceutically-acceptable carrier which includes lactic acid; and (d) a surfactant which comprises a block copolymer of propylene oxide and ethylene oxide. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
18. A topical antimicrobial or antiparasitic pharmaceutical composition comprising a safe and effective amount of a mixture comprising:
-
(a) a polyhydric alcohol monoester of lauric acid present in an amount of about 0.05 to about 2.0 percent by weight of the composition; (b) a binary mixture of fatty acids comprising; (i) a first fatty acid comprising capric acid, and (ii) a second fatty acid comprising caprylic acid; wherein (i) and (ii) are present in weight;
weight ratio of about 1;
10 to about 10;
1 and said binary mixture present in an amount of about 0.5 to about 8.0 percent by weight of the composition;(c) a pharmaceutically-acceptable carrier which includes a chelating agent; and (d) a surfactant which comprises a block copolymer of propylene oxide and ethylene oxide and which is present at a level of about 0.25 to about 10% by weight.
-
Specification